Biomedical applications of zinc oxide nanomaterials

Current Molecular Medicine

Volumn 13, Issue 10, 2013, Pages 1633-1645

  Zhang, Y ^a   Nayak, T R ^b   Hong, H ^b   Cai, W ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cancer; Drug delivery; Gene delivery; Molecular imaging; Nanosensor; Personalized medicine; Zinc oxide

Indexed keywords

CHOLESTEROL; DOXORUBICIN; FOLIC ACID; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; IRON OXIDE; NANOMATERIAL; NANOWIRE; PHENOL; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; UREA; ZINC OXIDE;

BIOMEDICAL ENGINEERING; BIOSENSOR; CANCER CELL; CANCER IMMUNOTHERAPY; CYTOTOXICITY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GENE TARGETING; GENETIC PROCEDURES; GLUCOSE SENSOR; HUMAN; MOLECULAR IMAGING; NANOSENSOR; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

ADULT; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOSTRUCTURES; NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH; ZINC OXIDE;

EID: 84889055797     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524013666131111130058     Document Type: Review

References (137)

1. Cai W, Hsu AR, Li ZB, Chen X. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2007; 2: 265-81.
2. Cai W, Hong H. In a "nutshell": intrinsically radio-labeled quantum dots. Am J Nucl Med Mol Imaging 2012; 2: 136-40.
3. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 2006; 58: 1460-70.
4. Hong H, Gao T, Cai W. Molecular imaging with single-walled carbon nanotubes. Nano Today 2009; 4: 252-61.
5. Hirsch LR, Gobin AM, Lowery AR, et al. Metal nanoshells. Ann Biomed Eng 2006; 34: 15-22.
6. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006; 34: 23-38.
7. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007; 3: 1840-54.
8. Zhang Y, Hong H, Myklejord DV, Cai W. Molecular imaging with SERS-active nanoparticles. Small 2011; 7: 3261-9.
9. Yigit MV, Medarova Z. In vivo and ex vivo applications of gold nanoparticles for biomedical SERS imaging. Am J Nucl Med Mol Imaging 2012; 2: 232-41.
10. Hong H, Zhang Y, Sun J, Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 2009; 4: 399-413.
11. Wang ZL. Splendid one-dimensional nanostructures of zinc oxide: a new nanomaterial family for nanotechnology. ACS Nano 2008; 2: 1987-92.
12. Yang P, Yan R, Fardy M. Semiconductor nanowire: what's next? Nano Lett 2010; 10: 1529-36.
13. Huang MH, Wu Y, Feick H, et al. Catalytic Growth of Zinc Oxide Nanowires by Vapor Transport. Adv Mater 2001; 13: 113-6.
14. Fan Z, Lu JG. Zinc oxide nanostructures: synthesis and properties. J Nanosci Nanotechnol 2005; 5: 1561-73.
15. Wang X, Liu J, Song J, Wang ZL. Integrated nanogenerators in biofluid. Nano Lett 2007; 7: 2475-9.
16. Lao CS, Park MC, Kuang Q, et al. Giant enhancement in UV response of ZnO nanobelts by polymer surface functionalization. J Am Chem Soc 2007; 129: 12096-7.
17. Yakimova R, Selegard L, Khranovskyy V, et al. ZnO materials and surface tailoring for biosensing. Front Biosci (Elite Ed) 2012; 4: 254-78.
18. Yang Y, Guo W, Zhang Y, et al. Piezotronic effect on the output voltage of P3HT/ZnO micro/nanowire heterojunction solar cells. Nano Lett 2011; 11: 4812-7.
19. Ozgur U, Alivov YI, Liu C, et al. A comprehensive review of ZnO materials and devices. J Appl Phys 2005; 98: 041301-103.
20. Liu D, Wu W, Qiu Y, et al. Surface functionalization of ZnO nanotetrapods with photoactive and electroactive organic monolayers. Langmuir 2008; 24: 5052-9.
21. Taratula O, Galoppini E, Wang D, et al. Binding studies of molecular linkers to ZnO and MgZnO nanotip films. J Phys Chem B 2006; 110: 6506-15.
22. Zhou J, Xu NS, Wang ZL. Dissolving Behavior and Stability of ZnO Wires in Biofluids: A Study on Biodegradability and Biocompatibility of ZnO Nanostructures. Adv Mater 2006; 18: 2432-5.
23. Huang X, Lee S, Chen X. Design of "smart" probes for optical imaging of apoptosis. Am J Nucl Med Mol Imaging 2011; 1: 3-17.
24. Cai W, Zhang Y, Kamp TJ. Imaging of induced pluripotent stem cells: from cellular reprogramming to transplantation. Am J Nucl Med Mol Imaging 2011; 1: 18-28.
25. Thorek DLJ, Robertson R, Bacchus WA, et al. Cerenkov imaging - a new modality for molecular imaging. Am J Nucl Med Mol Imaging 2012; 2: 163-73.
26. Wang RE, Niu Y, Wu H, Amin MN, Cai J. Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging 2011; 1: 36-46.
27. Heo YW, Norton DP, Pearton SJ. Origin of green luminescence in ZnO thin film grown by molecular-beam epitaxy. J Appl Phys 2005; 98: 073502-6.
28. Vanheusden K, Warren WL, Seager CH, et al. Mechanisms behind green photoluminescence in ZnO phosphor powders. J Appl Phys 1996; 79: 7983-90.
29. Zvyagin AV, Zhao X, Gierden A, et al. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Opt 2008; 13: 064031.
30. Kachynski AV, Kuzmin AN, Nyk M, Roy I, Prasad PN. Zinc Oxide Nanocrystals for Non-resonant Nonlinear Optical Microscopy in Biology and Medicine. J Phys Chem C Nanomater Interfaces 2008; 112: 10721-4.
31. Sudhagar S, Sathya S, Pandian K, Lakshmi BS. Targeting and sensing cancer cells with ZnO nanoprobes in vitro. Biotechnol Lett 2011; 33: 1891-6.
32. Xue F, Liang J, Han H. Synthesis and spectroscopic characterization of water-soluble Mn-doped ZnO(x)S(1-x) quantum dots. Spectrochim Acta A Mol Biomol Spectrosc 2011; 83: 348-52.
33. Wu YL, Fu S, Tok AI, et al. A dual-colored bio-marker made of doped ZnO nanocrystals. Nanotechnology 2008; 19: 345605.
34. Zhang W-Q, Lu Y, Zhang T-K, et al. Controlled Synthesis and Biocompatibility of Water-Soluble ZnO Nanorods/Au Nanocomposites with Tunable UV and Visible Emission Intensity. J Phys Chem C 2008; 112: 19872-7.
35. Wang H, Wingett D, Engelhard MH, et al. Fluorescent dye encapsulated ZnO particles with cell-specific toxicity for potential use in biomedical applications. J Mater Sci Mater Med 2009; 20: 11-22.
36. Yang SC, Shen YC, Lu TC, Yang TL, Huang JJ. Tumor detection strategy using ZnO light-emitting nanoprobes. Nanotechnology 2012; 23: 055202.
37. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538-44.
38. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005; 4: 435-46.
39. Xiong HM, Xu Y, Ren QG, Xia YY. Stable aqueous ZnO@polymer core-shell nanoparticles with tunable photoluminescence and their application in cell imaging. J Am Chem Soc 2008; 130: 7522-3.
40. Pan ZY, Liang J, Zheng ZZ, Wang HH, Xiong HM. The application of ZnO luminescent nanoparticles in labeling mice. Contrast Media Mol Imaging 2011; 6: 328-30.
41. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-80.
42. Liu Y, Ai K, Yuan Q, Lu L. Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging. Biomaterials 2011; 32: 1185-92.
43. Singh SP. Multifunctional magnetic quantum dots for cancer theranostics. J Biomed Nanotechnol 2011; 7: 95-7.
44. Hong H, Shi J, Yang Y, et al. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett 2011; 11: 3744-50.
45. Shi J, Hong H, Ding Y, et al. Evolution of Zinc Oxide Nanostructures through Kinetics Control. J Mater Chem 2011; 21: 9000-8.
46. Cai W, Chen X. Anti-angiogenic cancer therapy based on integrin avb3 antagonism. Anti-Cancer Agents Med Chem 2006; 6: 407-28.
47. Cai W, Niu G, Chen X. Imaging of integrins as biomarkers for tumor angiogenesis. Curr Pharm Des 2008; 14: 2943-73.
48. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010; 188: 759-68.
49. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683-93.
50. Alauddin MM. Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2012; 2: 55-76.
51. Cai W, Hong H. Peptoid and positron emission tomography: an appealing combination. Am J Nucl Med Mol Imaging 2011; 1: 76-9.
52. Eary JF, Hawkins DS, Rodler ET, Conrad EUI. 18F-FDG PET in sarcoma treatment response imaging. Am J Nucl Med Mol Imaging 2011; 1: 47-53.
53. Grassi I, Nanni C, Allegri V, et al. The clinical use of PET with 11C-acetate. Am J Nucl Med Mol Imaging 2012; 2: 33-47.
54. Iagaru A. 18F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge. Am J Nucl Med Mol Imaging 2011; 1: 63-4.
55. Vach W, Høilund-Carlsen PF, Fischer BM, Gerke O, Weber W. How to study optimal timing of PET/CT for monitoring of cancer treatment. Am J Nucl Med Mol Imaging 2011; 1: 54-62.
56. Aparici CM, Carlson D, Nguyen N, Hawkins RA, Seo Y. Combined SPECT and Multidetector CT for Prostate Cancer Evaluations. Am J Nucl Med Mol Imaging 2012; 2: 48-54.
57. Bhargava P, He G, Samarghandi A, Delpassand ES. Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine. Am J Nucl Med Mol Imaging 2012; 2: 221-31.
58. Ogasawara Y, Ogasawara K, Suzuki T, et al. Preoperative 123I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis. Am J Nucl Med Mol Imaging 2012; 2: 77-87.
59. Zeman MN, Scott PJH. Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging 2012; 2: 174-220.
60. Zhao R, Wang J, Deng J, Yang W, Wang J. Efficacy of 99mTc- EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy. Am J Nucl Med Mol Imaging 2012; 2: 242-7.
61. Zhang Y, Nayak TR, Hong H, Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 2012; 4: 3833-42.
62. Buckle T, van den Berg NS, Kuil J, et al. Non-invasive longitudinal imaging of tumor progression using an 111indium labeled CXCR4 peptide antagonist. Am J Nucl Med Mol Imaging 2012; 2: 99-109.
63. De Saint-Hubert M, Brepoels L, Devos E, et al. Molecular imaging of therapy response with 18F-FLT and 18F-FDG following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging 2012; 2: 110-21.
64. Sun M, Hoffman D, Sundaresan G, et al. Synthesis and characterization of intrinsically radio-labeled quantum dots for bimodal detection. Am J Nucl Med Mol Imaging 2012; 2: 122-35.
65. Hanley C, Layne J, Punnoose A, et al. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology 2008; 19: 295103.
66. Yuan Q, Hein S, Misra RD. New generation of chitosan- encapsulated ZnO quantum dots loaded with drug: synthesis, characterization and in vitro drug delivery response. Acta Biomater 2010; 6: 2732-9.
67. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 10: 475-80.
68. Cho NH, Cheong TC, Min JH, et al. A multifunctional core- shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat Nanotechnol 2011; 6: 675-82.
69. Guo D, Wu C, Jiang H, et al. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J Photochem Photobiol B 2008; 93: 119-26.
70. Li J, Guo D, Wang X, et al. The Photodynamic Effect of Different Size ZnO Nanoparticles on Cancer Cell Proliferation In Vitro. Nanoscale Res Lett 2010; 5: 1063-71.
71. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004; 5: 497-508.
72. Wilson BC, Patterson MS. The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 2008; 53: R61-109.
73. Zhang H, Chen B, Jiang H, et al. A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 2011; 32: 1906-14.
74. McCormick F. Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 2001; 1: 130-41.
75. Nie L, Gao L, Feng P, et al. Three-dimensional functionalized tetrapod-like ZnO nanostructures for plasmid DNA delivery. Small 2006; 2: 621-5.
76. Nie L, Gao L, Yan X, Wang T. Functionalized tetrapod-like ZnO nanostructures for plasmid DNA purification, polymerase chain reaction and delivery. Nanotechnology 2007; 18: 015101.
77. Zhang P, Liu W. ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging. Biomaterials 2010; 31: 3087-94.
78. Zhao Z, Lei W, Zhang X, Wang B, Jiang H. ZnO-Based Amperometric Enzyme Biosensors. Sensors (Basel) 2010; 10: 1216-31.
79. Wang JX, Sun XW, Wei A, et al. Zinc oxide nanocomb biosensor for glucose detection. Appl Phys Lett 2006; 88: 233106
80. Kumar SA, Chen SM. Nanostructured zinc oxide particles in chemically modified electrodes for biosensor applications. Anal Lett 2008; 41: 141-58.
81. Willander M, Al-Hilli S. ZnO nanorods as an intracellular sensor for pH measurements. Methods Mol Biol 2009; 544: 187-200.
82. Pachauri V, Vlandas A, Kern K, Balasubramanian K. Site specific self-assembled liquid-gated ZnO nanowire transistors for sensing applications. Small 2010; 6: 589-94.
83. Anish Kumar M, Jung S, Ji T. Protein biosensors based on polymer nanowires, carbon nanotubes and zinc oxide nanorods. Sensors (Basel) 2011; 11: 5087-111.
84. Zang JF, Li CM, Cui XQ, et al. Tailoring zinc oxide nanowires for high performance amperometric glucose sensor. Electroanalysis 2007; 19: 1008-14.
85. Weber J, Jeedigunta S, Kumar A. Fabrication and Characterization of ZnO Nanowire Arrays with an Investigation into Electrochemical Sensing Capabilities. J Nanomater 2008; 638523.
86. Wei A, Sun XW, Wang JX, et al. Enzymatic glucose biosensor based on ZnO nanorod array grown by hydrothermal decomposition. Appl Phys Lett 2006; 89: 123902.
87. Umar A, Rahman MM, Kim SH, Hahn YB. ZnO nanonails: synthesis and their application as glucose biosensor. J Nanosci Nanotechnol 2008; 8: 3216-21.
88. Dai ZH, Shao GJ, Hong JM, Bao JC, Shen J. Immobilization and direct electrochemistry of glucose oxidase on a tetragonal pyramid-shaped porous ZnO nanostructure for a glucose biosensor. Biosens Bioelectron 2009; 24: 1286-91.
89. Wei Y, Li Y, Liu X, et al. ZnO nanorods/Au hybrid nanocomposites for glucose biosensor. Biosens Bioelectron 2010; 26: 275-8.
90. Zhao ZW, Chen XJ, Tay BK, et al. A novel amperometric biosensor based on ZnO: Co nanoclusters for biosensing glucose. Biosens Bioelectron 2007; 23: 135-9.
91. Liu JP, Guo CX, Li CM, et al. Carbon-decorated ZnO nanowire array: A novel platform for direct electrochemistry of enzymes and biosensing applications. Electrochem Commun 2009; 11: 202-5.
92. Sung YM, Noh K, Kwak WC, Kim TG. Enhanced glucose detection using enzyme-immobilized ZnO/ZnS core/sheath nanowires. Sensor Actuat B-Chem 2012; 161: 453-9.
93. Hu FX, Chen SH, Wang CY, et al. ZnO nanoparticle and multiwalled carbon nanotubes for glucose oxidase direct electron transfer and electrocatalytic activity investigation. J Mol Catal B-Enzym 2011; 72: 298-304.
94. Kim KE, Kim TG, Sung YM. Enzyme-conjugated ZnO nanocrystals for collisional quenching-based glucose sensing. Crystengcomm 2012; 14: 2859-65.
95. Wang G, Xu JJ, Ye LH, Zhu JJ, Chen HY. Highly sensitive sensors based on the immobilization of tyrosinase in chitosan. Bioelectrochemistry 2002; 57: 33-8.
96. Dempsey E, Diamond D, Collier A. Development of a biosensor for endocrine disrupting compounds based on tyrosinase entrapped within a poly(thionine) film. Biosens Bioelectron 2004; 20: 367-77.
97. de Albuquerque YDT, Ferreira LF. Amperometric biosensing of carbamate and organophosphate pesticides utilizing screen-printed tyrosinase-modified electrodes. Analytica Chimica Acta 2007; 596: 210-21.
98. Liu ZM, Liu YL, Yang HF, et al. A mediator-free tyrosinase biosensor based on ZnO sol-gel matrix. Electroanalysis 2005; 17: 1065-70.
99. Li YF, Liu ZM, Liu YL, et al. A mediator-free phenol biosensor based on immobilizing tyrosinase to ZnO nanoparticles. Anal Biochem 2006; 349: 33-40.
100. Chen LY, Gu BX, Zhu GP, et al. Electron transfer properties and electrocatalytic behavior of tyrosinase on ZnO nanorod. J Electroanal Chem 2008; 617: 7-13.
101. Zhao J, Zhi J, Zhou Y, Yan W. A tyrosinase biosensor based on ZnO nanorod clusters/nanocrystalline diamond electrodes for biosensing of phenolic compounds. Anal Sci 2009; 25: 1083-8.
102. Gu BX, Xu CX, Zhu GP, et al. Tyrosinase Immobilization on ZnO Nanorods for Phenol Detection. J Phys Chem B 2009; 113: 377-81.
103. Zhao JW, Wu DH, Zhi JF. A novel tyrosinase biosensor based on biofunctional ZnO nanorod microarrays on the nanocrystalline diamond electrode for detection of phenolic compounds. Bioelectrochemistry 2009; 75: 44-9.
104. Lee JM, Xu GR, Kim BK, Choi HN, Lee WY. Amperometric Tyrosinase Biosensor Based on Carbon Nanotube-Doped Sol-Gel-Derived Zinc Oxide-Nafion Composite Films. Electroanalysis 2011; 23: 962-70.
105. Zhang YW, Zhang Y, Wang H, et al. An enzyme immobilization platform for biosensor designs of direct electrochemistry using flower-like ZnO crystals and nanosized gold particles. J Electroanal Chem 2009; 627: 9-14.
106. Liu YL, Yang YH, Yang HF, et al. Nanosized flower-like ZnO synthesized by a simple hydrothermal method and applied as matrix for horseradish peroxidase immobilization for electrobiosensing. J Inorg Biochem 2005; 99: 2046-53.
107. Cao X, Ning W, Li LD, Guo L. Synthesis and characterization of waxberry-like microstructures ZnO for biosensors. Sensor Actuat B-Chem 2008; 129: 268-73.
108. Gu BX, Xu CX, Zhu GP, et al. Layer by layer immobilized horseradish peroxidase on zinc oxide nanorods for biosensing. J Phys Chem B 2009; 113: 6553-7.
109. Sullivan DR. Screening for cardiovascular disease with cholesterol. Clin Chim Acta 2002; 315: 49-60.
110. Wilkinson IB, Cockcroft JR. Cholesterol, endothelial function and cardiovascular disease. Curr Opin Lipidol 1998; 9: 237-42.
111. Umar A, Rahman MM, Vaseem M, Hahn YB. Ultra-sensitive cholesterol biosensor based on low-temperature grown ZnO nanoparticles. Electrochem Commun 2009; 11: 118-21.
112. Singh SP, Arya SK, Pandey P, et al. Cholesterol biosensor based on rf sputtered zinc oxide nanoporous thin film. Appl Phys Lett 2007; 91: 063901.
113. Umar A, Rahman MM, Al-Hajry A, Hahn YB. Highly-sensitive cholesterol biosensor based on well-crystallized flowershaped ZnO nanostructures. Talanta 2009; 78: 284-9.
114. Ahmad M, Pan CF, Gan L, Nawaz Z, Zhu J. Highly Sensitive Amperometric Cholesterol Biosensor Based on PtIncorporated Fullerene-like ZnO Nanospheres. J Phys Chem C 2010; 114: 243-50.
115. Wang CY, Tan XR, Chen SH, et al. Highly-sensitive cholesterol biosensor based on platinum-gold hybrid functionalized ZnO nanorods. Talanta 2012; 94: 263-70.
116. Israr MQ, Sadaf JR, Asif MH, et al. Potentiometric cholesterol biosensor based on ZnO nanorods chemically grown on Ag wire. Thin Solid Films 2010; 519: 1106-9.
117. Israr MQ, Sadaf JR, Nur O, et al. Chemically fashioned ZnO nanowalls and their potential application for potentiometric cholesterol biosensor. Appl Phys Lett 2011; 98: 253705.
118. Rajesh, Bisht V, Takashima W, Kaneto K. An amperometric urea biosensor based on covalent immobilization of urease onto an electrochemically prepared copolymer poly (N-3- aminopropyl pyrrole-co-pyrrole) film. Biomaterials 2005; 26: 3683-90.
119. Solanki PR, Kaushik A, Ansari AA, Sumana G, Malhotra BD. Zinc oxide-chitosan nanobiocomposite for urea sensor. Appl Phys Lett 2008; 93: 163903.
120. Ali A, Ansari AA, Kaushik A, et al. Nanostructured zinc oxide film for urea sensor. Mater Lett 2009; 63: 2473-5.
121. Palomera N, Balaguera M, Arya SK, et al. Zinc oxide nanorods modified indium tin oxide surface for amperometric urea biosensor. J Nanosci Nanotechnol 2011; 11: 6683-9.
122. Ali SMU, Ibupoto ZH, Salman S, et al. Selective determination of urea using urease immobilized on ZnO nanowires. Sensor Actuat B-Chem 2011; 160: 637-43.
123. Rout CS, Raju AR, Govindaraj A, Rao CN. Ethanol and hydrogen sensors based on ZnO nanoparticles and nanowires. J Nanosci Nanotechnol 2007; 7: 1923-9.
124. Lei Y, Liu X, Yan X, et al. Multicenter uric acid biosensor based on tetrapod-shaped ZnO nanostructures. J Nanosci Nanotechnol 2012; 12: 513-8.
125. Usman Ali SM, Ibupoto ZH, Kashif M, Hashim U, Willander M. A Potentiometric Indirect Uric Acid Sensor Based on ZnO Nanoflakes and Immobilized Uricase. Sensors (Basel) 2012; 12: 2787-97.
126. Ibupoto ZH, Ali Shah SM, Khun K, Willander M. Electrochemical l-Lactic Acid Sensor Based on Immobilized ZnO Nanorods with Lactate Oxidase. Sensors (Basel) 2012; 12: 2456-66.
127. Leiterer C, Seise B, Slowik I, et al. DNA hybridization assay at individual, biofunctionalized zinc oxide nanowires. J Biophotonics 2013; 6: 143-7.
128. Yumak T, Kuralay F, Muti M, et al. Preparation and characterization of zinc oxide nanoparticles and their sensor applications for electrochemical monitoring of nucleic acid hybridization. Colloids Surf B Biointerfaces 2011; 86: 397-403.
129. Tawa K, Umetsu M, Hattori T, Kumagai I. Zinc oxide-coated plasmonic chip modified with a bispecific antibody for sensitive detection of a fluorescent labeled-antigen. Anal Chem 2011; 83: 5944-8.
130. Chang CC, Chiu NF, Lin DS, et al. High-sensitivity detection of carbohydrate antigen 15-3 using a gold/zinc oxide thin film surface plasmon resonance-based biosensor. Anal Chem 2010; 82: 1207-12.
131. Whitesides GM. Nanoscience, nanotechnology, and chemistry. Small 2005; 1: 172-9.
132. Service RF. Molecular electronics. Nanodevices make fresh strides toward reality. Science 2003; 302: 1310.
133. Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010; 7: 1063-77.
134. Muller KH, Kulkarni J, Motskin M, et al. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano 2010; 4: 6767-79.
135. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 2010; 4: 15-29.
136. Nair S, Sasidharan A, Divya Rani VV, et al. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 2009; 20 Suppl 1: S235-41.
137. Wang ZL. Nanostructures of zinc oxide. Mater Today 2004; 7: 26-33.